Carregant...
Venetoclax: a real game changer in treatment of chronic lymphocytic leukemia
Venetoclax – a novel, orally bioavailable inhibitor of B-cell lymphoma-2 – has demonstrated substantial clinical activity in the treatment of chronic lymphocytic leukemia. Alone or in combination with other targeted agents, venetoclax results in high rate of durable responses and undetectable measur...
Guardat en:
| Publicat a: | Int J Hematol Oncol |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Future Medicine Ltd
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7689538/ https://ncbi.nlm.nih.gov/pubmed/33294171 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/ijh-2020-0010 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|